First Header Logo Second Header Logo

Specific HDAC6 inhibition by ACY-738 reduces SLE pathogenesis in NZB/W mice.

Regna NL, Vieson MD, Luo XM, Chafin CB, Puthiyaveetil AG, Hammond SE, Caudell DL, Jarpe MB, Reilly CM. Specific HDAC6 inhibition by ACY-738 reduces SLE pathogenesis in NZB/W mice. Clin Immunol. 2016 Jan; 162:58-73.

View in: PubMed